Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
12.52
-0.18 (-1.42%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $364.65 million as of September 17, 2026. Its market cap has increased by 128.91% in one year.
Market Cap
364.65M
Enterprise Value
335.20M
1-Year Change
128.91%
Ranking
Category
Stock Price
$12.52
ChartMarket Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has increased from $289.30M to $364.65M, an increase of 26.05%. That is a compound annual growth rate of 1.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 364.70M | -19.88% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 378.46M |
| Galectin Therapeutics | 376.17M |
| Rocket Pharmaceuticals | 374.33M |
| Fennec Pharmaceuticals | 373.11M |
| Orchestra BioMed Holdings | 363.03M |
| Evommune | 362.56M |
| X4 Pharmaceuticals | 358.91M |
| Century Therapeutics | 358.53M |